“Treatment of the diabetic mice with losartan or paricalcitol (19-nor-1,25-dihydroxyvitamin D2, an activated vitamin D analog) alone moderately ameliorated kidney injury; however, combined treatment with losartan and paricalcitol completely prevented albuminuria, restored glomerular filtration barrier structure, and markedly reduced glomerulosclerosis.”